Reference
- TrecarichiEMTumbarelloMAntimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impactCurr Opin Infect Dis201427220021024573013
- MontefourKFriedenJHurstSAcinetobacter baumannii: an emerging multidrug-resistant pathogen in critical careCrit Care Nurse2008281152518238934
- ManchandaVSanchaitaSSinghNMultidrug resistant AcinetobacterJ Glob Infect Dis20102329130420927292
- ChiangMCKuoSCChenSJClinical characteristics and outcomes of bacteremia due to different genomic species of Acinetobacter baumannii complex in patients with solid tumorsInfection2012401192621887526
- TurkogluMMirzaETunçcanOGAcinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit: risk factors and impact on mortalityJ Crit Care201126546046721715136
- Durante-MangoniESignorielloGAndiniRColistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multi-center, randomized clinical trialClin Infect Dis201357334935823616495
- NazerLHRihaniSHawariFILeJHigh-dose colistin for microbiologically documented serious respiratory infections associated with carbapenem-resistant Acinetobacter baumannii in critically ill cancer patients: a retrospective cohort studyInfect Dis (Lond)2015471175576026050703
- HachemRYChemalyRFAhmarCAColistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patientsAntimicrob Agents Chemother20075161905191117387153
- DurakovicNRadojcicVBobanAEfficacy and safety of colistin in the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in patients with hematologic malignancy: a matched pair analysisIntern Med20115091009101321532223
- HoranTCAndrusMDudeckMACDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care settingAm J Infect Control200836530933218538699
- Clinical and Laboratory Standards Institute2007Performance standards for antimicrobial susceptibility testing-17th Informational supplementCLSI document M100-S17CLSIWayne, USA
- KellumJABellomoRRoncoCDefinition and classification of acute kidney injuryNephron Clin Pract20081094c182c18718802365
- DalfinoLPuntilloFMoscaAHigh-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary studyClin Infect Dis201254121720172622423120
- TrifiAAbdellatifSDalyFEfficacy and toxicity of high-dose colistin in multidrug-resistant gram-negative bacilli infections: a comparative study of a matched seriesChemotherapy201661419019626863534
- Álvarez-MarínRLópez-RojasRMárquezJAColistin dosage without loading dose is efficacious when treating carbapenem- resistant Acinetobacter baumannii ventilator-associated pneumonia caused by strains with high susceptibility to colistinPLoS One20161112e016846827992528
- PogueJMLeeJMarchaimDIncidence of and risk factors for colistin-associated nephrotoxicity in a large academic health systemClin Infect Dis201153987988421900484
- NazerLHKharabshehARimawiDMubarakSHawariFCharacteristics and outcomes of Acinetobacter baumannii infections in critically ill patients with cancer: a matched case-control studyMicrob Drug Resist201521555656126430944